Konidaris Tasos bought AMRX
March 3, 2026 · Form 4 insider transaction
Konidaris Tasos bought 45,290 shares of Amneal Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
45,290
Price
N/A
Total value
N/A
InsiderKonidaris Tasos
Role—
SecurityClass A Common Stock
Transaction codeM: Option exercise
Transaction dateMarch 3, 2026
Filing dateMarch 5, 2026
Shares owned after167,442
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.; Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.